EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma

European Journal of Cancer

Volumn 45, Issue 9, 2009, Pages 1700-1708

  Ryott, Michael ^a   Wangsa, Darawalee ^a,b   Heselmeyer Haddad, Kerstin ^b   Lindholm, Johan ^a   Elmberger, Göran ^a   Auer, Gert ^a   Lundqvist, Elisabeth Åvall ^a   Ried, Thomas ^b   Munck Wikland, Eva ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Fluorescence; Immunohistochemistry; In situ hybridisation; Mouth neoplasms

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PARAFFIN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE NUMBER; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ORAL TONGUE SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; STAINING; TONGUE CARCINOMA; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE DOSAGE; GENES, ERBB-1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMOKING; TONGUE NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 65849350702     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.02.027     Document Type: Article

References (33)

1. Shiboski C.H., Schmidt B.L., and Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the US population ages 20-44 years. Cancer 103 (2005) 1843-1849
2. Mendelsohn J., and Baselga J. Epidermal growth factor receptor targeting in cancer. Semin Oncol 33 (2006) 369-385
3. Riesterer O., Milas L., and Ang K.K. Combining molecular therapeutics with radiotherapy for head and neck cancer. J Surg Oncol 97 (2008) 708-711
4. Bentzen S.M., Atasoy B.M., Daley F.M., et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 23 (2005) 5560-5567
5. Gupta A.K., McKenna W.G., Weber C.N., et al. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res 8 (2002) 885-892
6. Huang S.M., and Harari P.M. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Clin Cancer Res 6 (2000) 2166-2174
7. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual. 6th ed. (2002), Springer
8. Shah N.G., Trivedi T.I., Tankshali R.A., et al. Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression. Int J Biol Mark 22 (2007) 132-143
9. Lim S.C., Zhang S., Ishii G., et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10 (2004) 166-172
10. Hirsch F.R., Varella-Garcia M., Bunn Jr. P.A., et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21 (2003) 3798-3807
11. Garnis C., Campbell J., Zhang L., Rosin M.P., and Lam W.L. OCGR array: an oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 40 (2004) 511-519
12. Bei R., Pompa G., Vitolo D., et al. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol 195 (2001) 343-348
13. Gebhart E., Ries J., Wiltfang J., Liehr T., and Efferth T. Genomic gain of the epidermal growth factor receptor harboring band 7p12 is part of a complex pattern of genomic imbalances in oral squamous cell carcinomas. Arch Med Res 35 (2004) 385-394
14. Mrhalova M., Plzak J., Betka J., and Kodet R. Epidermal growth factor receptor - its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas. Neoplasma 52 (2005) 338-343
15. Lee D.H., Lee G.K., Kong S.Y., et al. Epidermal growth factor receptor status in anaplastic thyroid carcinoma. J Clin Pathol 60 (2007) 881-884
16. Hanawa M., Suzuki S., Dobashi Y., et al. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer 118 (2006) 1173-1180
17. Massano J., Regateiro F.S., Januario G., and Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 67-76
18. Bettendorf O., Piffko J., and Bankfalvi A. Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?. Oral Oncol 40 (2004) 110-119
19. Sunpaweravong P., Sunpaweravong S., Puttawibul P., et al. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 131 (2005) 111-119
20. Brun E., Zatterstrom U., Kjellen E., et al. Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas. Acta Oncol 40 (2001) 491-496
21. Xia W., Lau Y.K., Zhang H.Z., et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5 (1999) 4164-4174
22. Sarbia M., Ott N., Puhringer-Oppermann F., and Brucher B.L. The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus. Brit J Cancer 97 (2007) 1404-1408
23. Chung C.H., Ely K., McGavran L., et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 24 (2006) 4170-4176
24. Panikkar R.P., Astsaturov I., and Langer C.J. The emerging role of cetuximab in head and neck cancer: a 2007 perspective. Cancer Invest 26 (2008) 96-103
25. Akimoto T., Hunter N.R., Buchmiller L., Mason K., Ang K.K., and Milas L. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res 5 (1999) 2884-2890
26. Wollman R., Yahalom J., Maxy R., Pinto J., and Fuks Z. Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. Int J Radiat Oncol Biol Phys 30 (1994) 91-98
27. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New Engl J Med 354 (2006) 567-578
28. Lindquist D., Romanitan M., Hammarstedt L., et al. Human Papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 87 (2007) 1-6
29. Sequist L.V., and Lynch T.J. EGFR tyrosine kinase inhibitors in lung cancer: an evolving story. Ann Rev Med 59 (2008) 429-442
30. Pao W., Miller V., Zakowski M., et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101 (2004) 13306-13311
31. Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New Engl J Med 350 (2004) 2129-2139
32. Miller V.A., Kris M.G., Shah N., et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 22 (2004) 1103-1109
33. Squire J.A., Bayani J., Luk C., et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 24 (2002) 874-887